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Damage to the central nervous system caused by traumatic injury or neurological 
disorders can lead to permanent loss of voluntary motor function and muscle paralysis. 
Here, we describe an approach that circumvents central motor circuit pathology to 
restore specific skeletal muscle function. We generated murine embryonic stem cell–
derived motor neurons that express the light-sensitive ion channel channelrhodopsin-
2, which we then engrafted into partially denervated branches of the sciatic nerve of 
adult mice. These engrafted motor neurons not only reinnervated lower hind-limb 
muscles but also enabled their function to be restored in a controllable manner using 
optogenetic stimulation. This synthesis of regenerative medicine and optogenetics 
may be a successful strategy to restore muscle function after traumatic injury or 
disease. 
 
Electrical stimulation of motor axons within peripheral nerves has been known to induce 
muscle contraction since Luigi Galvani’s early experiments. In more recent times, phrenic 
nerve pacing has been used clinically to control the function of the diaphragm, the major 
muscle involved in respiration, in some patients with high-level spinal cord injury (1) or 
amyotrophic lateral sclerosis (ALS) (2). However, peripheral nerves are composed of efferent 
motor axons as well as afferent sensory axons (which are unaffected in ALS). Functional 
electrical stimulation, which stimulates nerves indiscriminately, can thus cause considerable 
discomfort (3). Furthermore, functional electrical stimulation is ineffective if axon integrity is 
compromised because of injury or degenerative disease. Other strategies to replace lost motor 
neurons within the central nervous system include the use of embryonic stem cells (ESCs), 
but ESC-derived neurons do not always integrate into adult brain and spinal cord circuitry (4) 
and have difficulty overcoming molecular inhibitors of neuronal outgrowth (5) and extending 
axons across the barrier between the central and peripheral nervous system to reach the 
appropriate muscles (6).  
It has previously been shown that motor neurons derived from ESCs can be engrafted into a 
peripheral nerve environment and successfully reinnervate denervated muscle (7). However, 
these engrafted cells are not connected to the descending inputs within the central nervous 
system that normally control motor function; therefore, their neural activity must be regulated 
by an artificial control system. Such engrafted ESC-derived motor neurons can be electrically 
stimulated (7), but this approach stimulates endogenous as well as engrafted neurons. In 
transgenic mice that express the light-sensitive ion channel channelrhodopsin-2 (ChR2) (8, 9) 
in endogenous motor neurons, it has been shown that the axons of these ChR2 motor neurons 
can be recruited by optical stimulation in a physiological and graded fashion, resulting in 
optogenetic control of muscle function (10). It has also been shown that viral expression of 
ChR2 in motor neurons of adult rats can enable optical stimulation of muscle function (11). In 
this study, we tested whether expression of ChR2 in ESC-derived motor neurons engrafted 
into a denervated peripheral nerve (i) confers optically regulated control of muscle function, 
without interfering with endogenous motor signals or afferent sensory axons, and (ii) enables 
physiological recruitment of motor units. 
We generated genetically modified ESC-derived motor neurons that express both ChR2, to 
enable optical stimulation, as well as glial-derived neurotrophic factor (Gdnf), a neurotrophic 
factor that promotes long-term motor neuron survival (see supplementary materials and 
methods). To develop such ESCs suitable for in vivo engraftment of ESC motor neurons, we 
stably transfected an established mouse ESC clonal cell line that already carried the motor 
neuron–specific reporter Hb9::CD14-IRES-GFP (GFP, green fluorescent protein) (12) with a 
photoreceptor transgene that is expressed regardless of cell type, CAG::ChR2-YFP (YFP, 
yellow fluorescent protein), and with the neurotrophin-expressing CAG::Gdnf transgene. 
Embryoid bodies derived from CAG:ChR2-YFP/Gdnf ESCs, which express ChR2-YFP in all 
cells including motor neurons (Fig. 1A), were differentiated in vitro using an established 
protocol (13, 14). CAG::ChR2-YFP/Gdnf motor neurons also produce Gdnf (Fig. 1B), which 
improves their long-term survival in vitro (Fig. 1C). When cultured on an ESC-derived astrocyte 
feeder layer (fig. S1), ChR2 motor neurons mature electrically over a period of 35 days, until 
they fire trains of action potentials in response to optical stimulation and closely resemble adult 
motor neuron activity patterns induced by electrical stimulation (15) (Fig. 1D and fig. S2).  
After developing these ChR2 motor neurons, we next established an in vivo model to assess 
the feasibility of restoring muscle function with optical control of the engrafted cells, using the 
sciatic nerve. Muscle denervation was induced by sciatic nerve ligation in adult mice. This 
procedure results in a complete initial denervation, followed by limited regeneration of 
endogenous axons through the ligation site, thereby creating a partially denervated 
environment resembling the partial muscle denervation of early-stage ALS (fig. S3). Three 
days post-ligation, embryoid bodies containing ChR2 motor neurons were engrafted distal to 
the ligation into the tibial and common peroneal branches of the sciatic nerve. Histological 
analysis revealed that the engrafted ChR2 motor neurons not only survive for at least 35 days 
in the peripheral nerve environment (Fig. 2A), but also mature morphologically to resemble 
adult spinal motor neurons and express the mature motor neuron marker choline 
acetyltransferase (Fig. 2B). Immunodetection of ChR2-YFP, using an antibody to GFP, 
demonstrates that ChR2 is localized to the membrane of motor neurons, whereas direct 
detection of GFP versus YFP fluorescent signals reveals that Hb9-driven GFP expression is 
virtually absent in ChR2 motor neurons that have matured in vivo for 35 days (figs. S4 and 
S5). Additionally, ChR2 motor neurons extended large numbers of axons (Fig. 2C) distally 
toward both anterior [tibialis anterior (TA) and extensor digitorum longus (EDL)] and posterior 
[triceps surae (TS)] lower hind-limb muscles when grafted into the specific branches of the 
sciatic nerve that innervate these muscles. Engrafted ChR2 motor neuron axons, which grow 
alongside regenerating endogenous (YFP-negative) motor axons, are mostly myelinated (Fig. 
2D). Histological analysis also revealed robust reinnervation of muscle fibers by ChR2 motor 
neurons, although the neuromuscular junctions exhibited hallmarks of inactivity, including 
poly-innervation as well as collateral and terminal axonal sprouting (16) (Fig. 2E), most likely 
because these motor neurons were inactive in vivo until stimulated by the external optical 
signal. Nevertheless, quantification of all end plates within a whole TS muscle revealed that 
14.7% were innervated by YFP-positive ChR2 motor neurons axons after 35 days (Fig. 2F). 
Moreover, we observed YFP-positive neuromuscular junctions in both fast-twitch and slow-
twitch regions of the TS, indicating that ChR2 motor neurons can innervate different muscle 
types. Therefore, this time point (35 days) was used in subsequent experiments to establish 
whether the transplanted ChR2 motor neurons were indeed functional and responsive to 
optical stimuli in vivo.  
In anesthetized animals, we used isometric muscle tension physiology to examine the 
contractile responses elicited from TA, EDL, and TS (data summarized in table S1) muscles 
after optical stimulation of the exposed sciatic nerve using finely controlled pulses of 470nm 
blue light generated by a light-emitting diode (LED) unit and delivered via a light-guide to the 
graft site (Fig. 3A and movie S1). Short-duration (14ms) light pulses were able to induce 
submaximal twitch contractions in muscles innervated by transplanted ChR2 motor neurons 
(Fig. 3B), whereas high-frequency illumination (40 to 80Hz) induced tetanic muscle contraction 
(Fig. 3C) that can be repeated in a highly reproducible manner (Fig. 3D). Quantification of 
these contractile responses demonstrated that the ratio of tetanic to twitch force was 3.09 
±0.52 and 2.34 ±0.33 for TA and EDL muscles, respectively (Fig. 3E), similar to normal values 
in uninjured animals.  
Because nerve ligation enables regeneration of some endogenous motor axons, it was 
possible to directly compare the properties of these endogenous axons with those of the 
grafted ChR2 motor neurons by electrical nerve stimulation, which activates both populations 
of axons. This comparison demonstrated that the proportionate increase between twitch and 
tetanic stimuli after electrical stimulation was similar to that of optical stimulation [3.07 ±0.5 
and 2.96 ±0.3 for TA and EDL muscles, respectively) (table S1)], although maximal force 
generation induced by optical stimulation of ChR2 motor neurons was weaker in comparison 
with electrical recruitment of both ChR2-expressing and endogenous motor neurons (12.2% 
of electrically induced force for TA and 12.3% for EDL). It is likely that this reduced force output 
of muscle fibers innervated by ChR2 motor neurons reflects the 35-day period of inactivity 
preceding optical stimulation, as indicated by the findings of the histological analysis of these 
muscles, which showed the presence of axonal sprouting and poly-innervated end plates, 
characteristic features of inactive muscles (16). Sustained optical stimulation in vivo would 
probably lead to reinforcement of these neuromuscular junctions and a corresponding 
increase in force output. Analysis of muscle contractile characteristics also revealed that the 
latency to peak twitch contraction from initiation of the electrical trigger to the LED unit, or 
direct stimulation of the nerve, was identical for both optical and electrical stimulation (Fig. 3F). 
This finding indicates that the nerve conduction velocities were similar for both types of 
stimulation and supports the histological findings showing that axons of ChR2 motor neurons 
are myelinated (Fig. 2D). Additionally, the contraction rate—that is, the time from initiation of 
muscle contraction to peak contraction—was also very similar (Fig. 3G) for both forms of 
stimulation. Repetitive trains of optical or electrical stimuli (40Hz, 250ms duration, every 1s) 
were delivered for a period of 180s to investigate the fatigue characteristics of the reinnervated 
muscles, which normally have a fast-twitch, fatigable phenotype. The results showed that 
muscle fibers innervated by grafted ChR2 motor neurons were fatigue-resistant, in contrast to 
muscle fibers activated by electrical stimulation (Fig. 3H). Again, this probably reflects the 
prolonged period of inactivity of ChR2 motor neurons before optical stimulation.  
Simultaneous activation of all motor neurons innervating a specific muscle would result in 
inefficient spasmodic contraction and muscle fatigue. It is therefore important that motor 
neurons are recruited physiologically, according to their activation threshold, to generate a 
graded muscle contraction that is proportionate to the intended force output. Activation 
threshold is normally determined by motor neuron soma size (17), but in the case of 
optogenetic activation of motor neurons, axonal diameter and intermodal distance are also 
important factors (10, 18).With this in mind, it was important to determine whether grafted 
ChR2 motor neurons could also be recruited in a graded manner by optical stimulation to 
induce physiological motor-unit recruitment, where smaller motor units are recruited before 
larger motor units. To test this, the illumination intensity of the LED was varied from 0.8 to 
8mW/mm2, which resulted in stochastic increases in muscle contractile force, demonstrating 
that different motor units could be recruited according to their optical activation threshold (Fig. 
3I). This technique also enabled us to count the number of individual motor units innervating 
a given muscle, which for the TA muscle was 15 ±3.03. Furthermore, by comparing optical 
and electrical nerve stimulation, we found that grafted ChR2 motor neurons accounted for 
~50% of all motor units (Fig. 3J). Moreover, the motor-unit counts enabled us to calculate the 
average motor-unit force (Fig. 3K), which, after optical stimulation, was found to be 0.21 
±0.04g and 0.16 ±0.05g for TA and EDL muscles, respectively. Combined recruitment of 
endogenous and ChR2 motor neuron axons by electrical stimulation resulted in average motor 
unit force values of 0.67 ±0.04 g and 0.59 ±0.34g for TA and EDL muscles, respectively, 
consistent with normal motor-unit force (0.62g). 
In this study, we show that ChR2 motor neurons can be successfully transplanted into a 
peripheral nerve, where they can survive and extend axons that not only replace lost 
endogenous motor axons but also reinnervate denervated muscle fibers. Moreover, these 
transplanted ChR2 motor neurons can be selectively activated by 470nm light, in a controlled 
manner to produce graded muscle contractions. Major challenges still remain before this 
approach can be established as an effective clinical intervention: These obstacles include the 
development of an implantable optical stimulator, such as that shown by Towne et al. (11), 
and a means to encapsulate the grafted cells. Additionally, incorporation of sensitive, red-
shifted channelrhodopsin variants, such as ReaChR (19), rather than ChR2 would abrogate 
potential cellular toxicity associated with short-wavelength light (20).  
These results show that through the use of a synthesis of regenerative medicine and 
optogenetics, it is possible to restore specific motor nerve functions. Although this study is 
largely a proof-of-principle study, it is possible that with further development this strategy may 
be of use in conditions where muscle function is lost—for example, after traumatic injury or 
neurodegenerative disease. 
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Figure 1 | Expression of Gdnf in ChR2+ESC-MNs enhances survival and enables them 
to mature electrically in vitro.  (A) Embryoid bodies derived from CAG::ChR2-YFP/Gdnf 
transgenic ESCs and parental controls stained for the pan-motor neuron marker Isl1/2. GFP 
and YFP signals were detected by direct fluorescence. (B) Confocal images of MACS sorted 
ESC motor neurons derived from CAG::ChR2-YFP (MACS, magnetic-activated cell sorting) 
and CAG::ChR2-YFP/Gdnf ESCs immunostained for Gdnf and GFP/YFP. (C) Survival 
analysis of sorted CAG::ChR2-YFP and CAG::ChR2-YFP/Gdnf ESC motor neurons (MNs) 
(200 cells per well) plated on ESC astrocytes at indicated time points. CAG::ChR2-YFP motor 
neurons were cultured with (10 ng/ml) or without recombinant Gdnf (two replicates, analysis 
of variance with Bonferroni correction, *P < 0.25). Error bars indicate SEM. One representative 
of three separate experiments is shown. Wt, wild type. (D) Optogenetic stimulation (blue bars) 
of CAG::ChR2-YFP/Gdnf ESC motor neurons cultured on ESC astrocytes. Scale bars in (A) 
and (B), 50 mm. 
Figure 2 | Robust axonal growth and reinnervation of distal muscles following 
engraftment of ChR2+ESC-MNs. (A) Image montage of a whole nerve and muscle section 
showing ChR2 motor neuron cell bodies at the graft site and axon projection (dashed lines 
indicate approximate trajectory). Scale bar, 500µm. (B) Confocal image of engrafted ChR2 
motor neurons immunolabeled for choline acetyltransferase (ChAT; left image) and GFP 
and/or YFP (merged image at right). Scale bar, 50µm. (C) Confocal image of longitudinal and 
transverse common peroneal nerve sections showing both ChR2 motor neurons and 
endogenous axons. Scale bar, 50µm. (D) Confocal images of engrafted ChR2 motor neuron 
axons showing myelination. Scale bar, 50µm. (E) Confocal z-stack of ChR2 motor neuron 
axon terminals innervating multiple neuromuscular junctions within the TS muscle. Arrows 
indicate pre-terminal collateral sprouting, arrowheads denote terminal sprouting, and the 
asterisk indicates an endogenous motor axon. Scale bar, 50µm. (F) Two-dimensional 
projection image of a TS muscle showing proportion of neuromuscular junctions (NMJs) 
innervated by engrafted ChR2 motor neurons, relative to the total number of end plates 
present [labeled with a-bungarotoxin (aBTx)]. Quantification is shown below. Representative 
images shown here are compiled from n=4 engrafted nerves from three separate experiments. 
Figure 3 | Restoration of muscle function, in a highly controlled manner, using optical 
stimulation of engrafted ChR2+ESC-MNs in vivo. (A) Schematic showing optical stimulation 
and isometric muscle tension recordings. EB, embryoid body. Representative twitch (B), 
tetanic (C), and repetitive tetanic (D) contraction traces obtained from the TA muscle, induced 
by optical stimulation. Blue line, muscle force; red line, electrical trigger signals sent to the 
LED unit. (E) Quantification of twitch and tetanic contraction of TA and EDL muscles. Time to 
peak contractile force, from initiation of the electrical trigger to the LED unit (F) or from the 
initiation of muscle contraction (G), is shown alongside direct electrical nerve stimulation (n-
values represent optical/electrical stimulation, respectively, compiled from four separate 
experiments). (H) Representative fatigue traces from TA muscles (different animals) produced 
by optical (top) or electrical (bottom) stimulation for 180s. (I) Representative TA muscle optical 
stimulation motor-unit number estimate trace. The asterisk indicates square-wave trigger 
voltage to the LED unit and oscilloscope trigger. (J) Motor-unit number quantification of TA 
and EDL muscles after optical versus electrical stimulation. (K) Analysis of average motor-unit 
force. The dashed line indicates the normal EDL value. All error bars indicate SEM. 
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SUPPLEMENTARY MATERIALS AND METHODS 
Materials and Methods 
 
Generation of stable ESC transfectants 
Hb9::CD14-IRES-GFP ‘bacterial artificial chromosome’ transgenic ESCs (clone H14IG#13) 
(12) were equipped with a ubiquitously expressed ChR2H134R-YFP transgene by stable 
transfection of a tol2L/R flanked expression vector consisting of the CAG promoter (21), 
followed by a 5’ splice substrate, the ChR2-YFP gene, a bovine growth hormone (bGH) poly-
adenylation sequence and a FRT-zeo-FRT resistance marker. 10 μg of the ptol2-CAG::ChR2-
YFP/FRT-zeo construct and 20 μg of pCAGGS-Tol2-TP Tol2 transposase expression vector 
(kindly provided by Koichi Kawakami) were co-electroporated into H14IG#13 ESCs using a 
XCell GenePulser (Biorad) and the following settings: ‘exponential mode’, 240 V, 500 μF, 4 
mm cuvettes. Recombinant ESC clones were selected with 50 μg/ml zeocin (Invitrogen) on 
mitomycin-C-(MMC) treated mouse embryonic fibroblasts, picked after 6 days based on YFP 
fluorescence, sub-cloned again, expanded and tested for the continued presence of the 
Hb9::CD14-IRES-GFP  transgene by assessing their resistance to G418 (Invitrogen; 
350μg/ml). Positive ESC clones were then screened for ChR2-YFP expression in motorneurons 
by in vitro differentiation, followed by fluorescence microscopy and electrophysiology. Clone 
Hb9::CD14-IRES-GFP#13/CAG::ChR2-YFP#1A (H14IG#13/CCRY#1A) was selected for 
further modification. This ESC sub-clone was then transfected with a transgene construct 
containing the CAG promoter, a 5’ spice substrate, the mouse Gdnf gene, a bGH poly-
adenylation sequence and a loxP-hygro-loxP resistance marker. The construct was flanked with 
piggyBAC terminal repeat sequences. 10 μg of the pPB-CAG::Gdnf/FRT-hygro construct and 
20 μg of p3xP3-DsRed1-orf piggyBAC transposase expression vector (kindly provided by 
Malcolm J. Fraser) were co-electroporated into H14IG#13/CCRY#1A ESCs and recombinant 
ESC clones were selected with 150 μg/ml hygromycin (Invitrogen) on hygromycin-resistant 
MMC-treated mouse embryonic fibroblasts, picked, expanded and screened for Gdnf 
expression by immunohistochemistry, and clone H14IG#13/CCRY#1A/CG#9G was chosen 
for subsequent experiments. 
To produce an ESC clone that would specifically express the MACS-sortable reporter gene 
human CD14 in astrocytes, we prepared a transgene construct that consisted of the human 
GFAP (gfa2) promoter (22) (kindly provided by Michael Brenner), followed by a 5’splice 
substrate (23), the CD14 open reading frame, a bGH poly-adenylation sequence and a FRT-
neo-FRT resistance marker (fig. S1A). This construct was flanked by tol2L/R recognition 
sequences (24). 10 μg of the ptol2-GFAP::CD14-I-GFP/FRT-neo construct and 20 μg of 
pCAGGS-Tol2-TP Tol2 transposase expression vector were co-electroporated into IB10 ESCs 
(25). Recombinant ESC clones were selected with 350 μg/ml G418 on G418-resistant MMC-
treated mouse embryonic fibroblasts, picked, expanded and then screened for astrocyte-specific 
CD14 expression by in vitro differentiation, followed by immunohistochemistry. Clone 
GFAP::CD14#H6 (G14#H6) was selected for subsequent experiments. The tol2-insertion site 
in clone G14#H6 was mapped to the Ntm gene (chromosome 9.A4) by inverse PCR (26). We 
have been unable to identify the insertion sites in clone CCRY#1A/CG#9G.  
ESC differentiation and MACS isolation of ESC-motorneurons and ESC-astrocytes 
Motorneuron differentiation from Hb9::CD14-IRES-GFP ESCs (clone H14IG#13) and 
derivatives was performed as described by Peljto et al (14). ESC-motorneurons were isolated 
from dissociated day 5 embryoid bodies by anti-CD14 MACS enrichment as previously 
described (12). Astrocytes were generated and isolated from GFAP::CD14 ESCs (clone 
G14#H6) as follows: Undifferentiated ESC colonies were dissociated with 0.25% Trypsin 
(Invitrogen) and grown in suspension in uncoated plastic dishes (Corning) to promote 
embryoid body formation. In the first 2 days, embryoid bodies were cultured in ADFNK 
medium (Advanced-DMEM/F12 (Invitrogen) and Neurobasal medium (Invitrogen) mixed at 
1:1 ratio supplemented with 2 mM L-Glutamine, 0.1 mM 2-mercaptoethanol (Sigma), 10% 
knock-out serum replacement (Invitrogen), and 1x Penicillin/Streptomycin). For the 
subsequent 3 days the embryoid bodies were cultured in ADFNK medium supplemented with 
1 μM retinoic acid (Sigma) and 0.5 μM Smoothened Agonist (SAG; Merck). At day 5 of 
differentiation, the embryoid bodies were re-plated onto 10cm tissue culture plates (Nunc) 
coated with GFR-matrigel (BD Biosciences) and cultured until day 12 in ADFNK medium. 
Then, the adherent embryoid bodies were washed once with PBS and dissociated with 
Accumax (Millipore; 6ml/plate) for 15 minutes at 37C. The cell aggregates were broken into 
single cells by pipetting and washed three times (1200 rpm, 4 minutes) with L15 medium 
supplemented with 10 U/ml of DNase-I (Roche). The cells were then re-suspended in 2 ml of 
MACS buffer (PBS supplemented with 0.5% BSA (Sigma) and 10 U/ml of DNase-I) and 
passed through a 40 μm nylon strainer (BD Biosciences). The cells were centrifuged at 1200 
rpm for 4 minutes, re-suspended in 200 μl of MACS buffer containing 5 μg/ml mouse anti-
human CD14 (clone 26ic, ATCC), incubated at 10C for 15 minutes, washed and then 
incubated with goat anti-mouse IgG MicroBeads (Miltenyi) diluted 1:10 in MACS buffer. After 
the secondary antibody incubation the cells were washed again, re-suspended in 600 μl of 
MACS buffer and applied to a MS magnetic column mounted in an OctoMACS magnet 
(Miltenyi). The column was washed three times with 500 μl MACS buffer, and the positive 
fraction eluted with 1 ml MACS buffer, following the manufacturer’s instructions. In some 
experiments, the pre-MACs and eluate cell fractions were stained with anti-CD14 antibody 
conjugated to phycoerythrin (Millipore) and reanalysed using a Guava EasyCyte HT flow 
cytometer (Millipore). The astrocyte sort cell fractions were also cultured for 2 days on 
matrigel-coated 8-well permanox-slides (Nunc) in ADFNK medium and then fixed and 
analysed by immunocytochemistry. 
Immunocytochemistry  
Embryoid bodies were fixed in 4% paraformaldehyde/0.1M phosphate buffer for 30 minutes 
on ice, washed three times in PBS, equilibrated in 0.1M phosphate buffer/30% sucrose for 15 
minutes, embedded in OCT and sectioned on a cryostat (Zeiss) at a thickness of 20 μm. 
Cultured cells were fixed for 20 minutes in 0.1M phosphate buffer /15% sucrose/4% 
paraformaldehyde and then washed with PBS three times. For CD14 detection on astrocytes, 
live cultured cells were stained with mouse anti-CD14 antibody (UCHM1, AbD Serotec; 10 
μg/ml) for 30 minutes at RT in medium, washed five times with PBS and then fixed as 
described above. To detect Gdnf protein in cultured ESC-motor neurons, the cells were 
incubated with 10μg/ml brefeldin A (Sigma) in medium at 37C for 1 hour prior to fixation. 
Antibody incubation was performed in PBS/0.1% TritonX-100/3% BSA using the following 
primary and secondary antibodies: rabbit anti-Isl1/2 (Epitomics, Burlingame, USA), rabbit 
anti-GFP (Invitrogen), goat anti-Gdnf (R&D Systems), rabbit anti-Gfap (DAKO), Alexa Fluor 
568 donkey anti-goat IgG, Alexa Fluor 568 donkey anti-mouse IgG and Alexa Fluor 488 
donkey anti-rabbit IgG (all secondary antibodies were obtained from Invitrogen). DNA 
counterstaining was carried out by adding 0.2 μM TOPRO3 (Invitrogen) to the secondary 
antibody labelling mix.  
In vitro electrophysiology 
All electrophysiology data was obtained from visually targeted whole-cell patch-clamp 
recordings of ESC-motorneurons 3-35 days post sorting by MACS. The cultures were 
maintained for the duration of the patching protocol in an HBS extracellular solution (pH 7.4, 
~280 mOsm) at room temperature that also contained (in mM): 136 NaCl, 2.5 KCl, 10 HEPES, 
10 D-glucose, 2 CaCl2 and 1.3 MgCl2. Pipettes were pulled from borosilicate glass (out 
diameter 1.5 mm, inner diameter 1.17 mm, Harvard Apparatus), with a resistance of 3-6 MΩ, 
and were filled with an internal solution containing (in mM): 130 K-gluconate, 10 NaCl, 1 
EGTA, 0.133 CaCl2, 2 MgCl2, 10 HEPES, 3.5 MgATP, 1 NaGTP. Recordings were acquired 
with the Pulse software linked to a HEKA EPC10/2 amplifier. Signals were Bessel filtered at 
10 kHz (filter 1), and 2.9 kHz (filter 2), digitized and sampled at 25-50 kHz (20-40 µs sample 
interval). Fast capacitance was compensated for in the on-cell configuration.  
Analysis of action potential characteristics was carried out in current clamp mode from a 
resting membrane potential of approximately -60 mV. We provided 10 ms duration current 
steps of increasing amplitude (increments of 2, 5 or 10 pA), injected at the soma until the 
neuron reliably fired an action potential (Vm > 0 mV). The properties of the action potential 
were obtained from the first spike elicited for each neuron. For evaluation of firing behavior in 
response to long current injections, cells were typically held at around -60mV in current clamp 
mode and subjected to either 500ms duration current steps of increasing amplitude (increments 
of 10 or 20pA) or a 500 ms duration blue (~488nm at 170 mW/mm2) light exposure provided 
by a shutter-controlled Xenon-arc lamp (Lambda-LS, Sutter Instruments, UK) with appropriate 
excitation filters (Chroma Tech. Corp., USA) but no neutral density filtering. Analysis of 
electrophysiological data was performed using custom-written functions in Matlab 
(Mathworks). 
Surgical engraftment of EBs containing ChR2-motorneurons in ligated sciatic nerve 
All procedures and experiments involving animals were carried out under License from the UK 
Home Office in accordance with the Animals (Scientific Procedures) Act 1986 (Amended 
Regulations 2012) and following ethical approval from UCL Institute of Neurology. Briefly, 8 
week old female C57Bl6/J mice (Harlan Laboratories UK), n = 19, underwent sciatic nerve 
ligation: under deep anaesthesia (isoflurane) and using aseptic surgical conditions, the sciatic 
nerve was exposed and a 6-0 EthiconTM suture thread was tied tightly around the nerve in the 
upper thigh region; prophylactic analgesia was administered (buprenorphine, 0.05 mg/kg) and 
following wound closure animals were closely monitored and allowed to recover for 3 days 
(the refractory period during which axonal growth is inhibited by myelin debris). After 3 days, 
the sciatic nerve was re-exposed, distal to the ligation site, and embryoid bodies (at Day 5 of 
the differentiation protocol, described above, which had been harvested and stored in ice-cold 
media prior to engraftment for <4 hrs) were injected into the tibial nerve and common peroneal 
nerve branches of the sciatic nerve using a 10μl Hamilton syringe with a customized 33G 
needle; typically 3-5 embryoid bodies were injected into each nerve branch in a volume of 
0.5μl. Again, following wound closure, prophylactic analgesia was administered and recovery 
of animals was closely monitored during the post-surgical period. A subset of animals (n = 8) 
received grafts containing MACS-sorted, purified ChR2-motorneurons (approximately 10,000 
cells/μl, injected in a volume of 0.5μl). These engrafted ChR2-motorneurons were capable of 
surviving in vivo for up to 35 d, however, the relatively small number of axons (compared to 
EB grafts) led to limited muscle innervation, therefore EB grafts were used for most 
experiments to provide the maximum innervation in this proof-of-principle study. EB engrafted 
mice (n = 11) and purified ChR2-motorneuorns engrafted mice (n = 8, representative example 
shown in fig. S5) underwent histological analysis at varying intervals following engraftment to 
determine survival and axonal growth and myelination of ChR2-motorneurons, and to 
determine muscle fibre innervation, as described below. N-values reflect data presented in this 
paper, rather than development of this strategy; only a subset of animals (n = 5) underwent 
optical/electrical nerve stimulation and physiological muscle recording (see below). 
Additionally, since the outcome measure of this study was unequivocal, randomization and 
blinding of groups was not necessary. 
Immunohistochemistry 
Animals were euthanized with an overdose of pentobarbital sodium (140mg/kg), and tissue 
was immediately removed; whole sciatic nerve (including tibial nerve and common peroneal 
nerve branches) were carefully dissected, maintaining connection to the triceps surae muscle 
to obtain a whole muscle/nerve preparation; tibialis anterior and extensor digitorum longus 
muscles were also removed. Tissue was fixed to a silicon mounting block, using insect pins, 
and then immersed in 4% paraformaldehyde in tris-buffered saline (TBS), and post-fixed for 
2hrs at 4°C and then transferred to 20% sucrose solution, in TBS, for cryoprotection and 
incubated at 4°C overnight. Samples were then carefully mounted in O.C.T. (Tissue-Tek 4583) 
medium, within flat-bottomed aluminum foil moulds, maintaining the whole muscle/nerve 
preparation in a horizontal plane; the moulds were then frozen on dry-ice. Serial longitudinal 
frozen sections (20μm) were then cut from the entire tissue block using a BrightTM crysostat 
and sections were mounted onto poly-lysine coated slides (VWR 631-0107). After being air-
dried (>2hr at room temperature), sections were immunostained according to standard 
protocols; briefly, sections were washed 3x with TBS, blocked with 5% normal donkey serum 
(NDS) in TBS containing 0.2% triton-X100 (TBS+), and primary antibodies (see below) in 2% 
NDS, in TBS+ were applied to the sections and incubated overnight at room temperature. 
Sections were then washed 3x with TBS and secondary antibodies (see below) in 2% NDS, in 
TBS+ were then applied for 1hr at room temperature – note: where applicable, α-bungarotoxin-
TRITC (Sigma T0195, used 1:500), FluoromyelinTM (Molecular Probes F34652, used 1:300),  
and DAPI (Sigma D9542; used 1:1,000) were mixed with secondary antibody solution. Finally, 
sections were washed 3x with TBS and the coverslips were mounted using fluorescent 
mounting medium (DAKO) and allowed to dry.  
For 3-D reconstruction of serial sections from a whole TS muscle, low magnification images 
were acquired using a Leica DMR epiflourescence microscope, and images were montaged 
using photoshop and then compiled into an aligned stack and 3-D reconstruction was performed 
using MetamorphTM software. For all other image acquisition a Zeiss LM710 laser scanning 
confocal microscope was used. Primary antibodies used were: Rabbit anti-GFP (Molecular 
Probes A-11122, used 1:500), Goat anti-Choline Acetyltransferase (Millipore, AB144P, used 
1:100) and Cy3-conjugated mouse anti-glial fibrillary acid protein (GFAP; Sigma C9205, used 
1:1,000). Secondary antibodies used were: donkey anti-goat-Alexa568 (Molecular Probes A-
11057, used 1:500), donkey anti-rabbit-Alexa488 (Molecular Probes A-21206, used 1:500). 
In vivo isometric muscle tension physiology using optical and electrical stimulation 
The remaining animals (n = 5) that had undergone ChR2-motorneuron engraftment were 
deeply anaesthetized using isoflurane and the right lower hind-limb muscles were prepared for 
physiological recording (at 35d post-engraftment), as previously described (27). Briefly, the 
distal tendons of the triceps surae, tibialis anterior and extensor digitorum longus muscles were 
exposed, severed and individually connected to a force transducer. The lower hind-limb was 
immobilized, and the sciatic nerve was exposed at the mid-thigh level, and the overlying 
muscles were retracted. A light guide, connected to a 470nm LED light source (CoolLED; pE-
100-LG), was then positioned 10 mm above the exposed, intact sciatic nerve. The control unit 
of the LED light source was connected to a Digitimer D4030 unit via a TTL trigger, which 
enabled pulses of light to be delivered for precise durations ranging from 5-50 ms, which were 
either delivered individually, to elicit twitch muscle contractions, or as repetitive high 
frequency (10-100 Hz, 450 ms duration) illumination, to elicit tetanic muscle contraction. Since 
40Hz optical stimulation (12.5 ms illumination, 12.5 ms dark, per cycle) elicited the maximal 
contractile response, this pulse duration and frequency were employed as the standard optical 
stimulation paradigm. Additionally, the light-intensity could also be varied between 0-100% 
(0-80mW/mm2) using the LED control unit; maximal responses were observed at 10% 
(8mW/mm2), therefore this was used as the upper limit when recording motor unit traces. For 
electrical stimulation, the light guide was removed, and the sciatic nerve was severed 
proximally and the distal nerve stump (containing the engrafted ChR2-motorneurons) was 
placed in contact with a platinum electrode, as previously described (27). All muscle responses 
(and TTL trigger pulses) were recorded via an oscilloscope using PicoscopeTM software. 
Statistical analysis: 
For motorneuron survival count analysis and comparison of optical versus electrical isometric 
muscle tension physiology recordings, One-way ANOVA analysis was performed at each time 
point (where applicable) and Bonferroni post-hoc correction for multiple testing was applied. 
Normal distribution was confirmed for each data set. All error bars shown represent S.E.M.  
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Extended Data 
Extended Data Table 1 | Summary of data from in vivo isometric muscle tension 
physiology recordings obtained using optical and electrical stimulation. Summary of 
data from 3 separate experimental groups, showing optical stimulation values in blue boxes 
and electrical stimulation values in grey boxes. Data represents average values +/- S.E.M. 
(shown in parentheses); n-values for each muscle indicated in left-hand column; *,**,** 
denotes MU number estimate and MU Force data obtained from n = 2, 4 and 3 separate 
recordings, respectively. 
 
 
Extended Data Figure legends: 
Extended Data Figure 1 | Magnetic enrichment of GFAP::CD14+ astrocytes from ESC 
differentiation cultures (a) Schematic representation of the GFAP::CD14 transgene 
construct used to generate stable mouse ESC lines. 5’S: 5’ splice substrate; pA: 
polyadentylation site; tol2R/tol2L: Tol2 transposase recognition sites. (b) The histogram 
shows flow cytometric analysis of anti-CD14 MACS enrichment of dissociated day 12 ESC 
differentiation cultures. Blue: pre-MACS; red: MACS eluate. (c) Pre-MACS, flow through and 
eluate from the anti-CD14 MACS-enrichment were plated out on matrigel-coated tissue culture 
dishes, cultured for 3 days and then fixed and immunostained for CD14 and Gfap. The 
percentages of CD14+ cells (counted from three representative images each) are shown in 
the upper right corners. Scale bar = 50μm 
Extended Data Figure 2 | Responses of ESC-derived MNs to electrical and optical 
stimulation in vitro. Representative current clamp traces from ChR2+ESC-MNs stimulated 
with a 500ms current injection (top row), or a 500ms blue light pulse (blue bar; bottom row). 
All cells were cultured on monolayers of ESC-derived astrocytes expressing a constitutively 
active Gdnf transgene (see Extended Data Fig. 1). Cells were held at -60mV for recording. (b) 
Analysis of single action potentials of ChR2+ESC-MNs stimulated with a 10ms current 
injection in current clamp mode. Mean Rm values for 3, 7, 21 and 35 DIV MNs were 581.2 
(n=6), 369.4 (n=4), 109.6 (n=8) and 76.3MΩ (n=10) respectively. (c) The output from 
ChR2+ESC-MNs was obtained from step-wise current injections of increasing amplitude (500 
ms) at the soma in current clamp mode (example voltage traces shown in (a)). The graph 
represents the number of action potentials fired during a 500 ms current pulse (expressed as 
mean frequency) as a function of input current density. Note how immature ChR2+ESC-MNs 
(DIV 3-7) cannot sustain high frequency firing compared to more mature neurons (DIV 21-35). 
By DIV 35, neurons can fire at average rates that go beyond 50Hz. The gradual shift of input-
output curves to the right (along the input current axis) as development progresses is likely 
due to the increase in Cm and decrease in Rm as neurons grow and mature. Cells were 
stimulated from a resting membrane potential of -60mV. DIV = Days in vitro. All error bars 
show ± S.E.M.  
Extended Data Figure 3 | Engrafted purified ChR2+ESC-MNs survive in vivo and avoids 
the presence of dividing cells. Confocal images of engrafted GFP/YFP-positive EBs (+35d 
in vivo) showing the presence of MNs immunostained for ChAT (a) and astrocytes, 
immunostained for GFAP (b); both MN somas and astrocytes remained confined to the graft-
site and did not migrate within the nerve (data not shown). (c) Image of engrafted purified 
ChR2+ESC-MNs showing that they can survive for the same duration (+35d) as ChR2+ESC-
MNs within EBs, and that all GFP/YFP immunostaining co-localizes with ChAT, indicating the 
absence of other contaminating cell populations. Scale bars = 50μm. 
 
 
 
 
  
